Generate a tailored SOP for Dr. Mitchell Lazar. Improve your application with a focused, well-structured draft.
Mitchell Lazar is a prominent researcher in the field of metabolism and diabetes, holding the position of Willard Rhoda Ware Professor at the University of Pennsylvania's Perelman School of Medicine. His research primarily focuses on transcriptional regulation of metabolism, particularly the role of nuclear receptors (NRs) in various metabolic processes. Dr. Lazar's laboratory investigates how NRs, in the absence of ligands, can act as potent transcriptional repressors by recruiting corepressor complexes that include histone deacetylase 3 (HDAC3). He is particularly interested in the mechanisms linking circadian rhythms to metabolism, studying the nuclear receptor Rev-erb alpha, which plays a critical role in coordinating metabolism with biological rhythms. Dr. Lazar's research has also delved into the PPAR gamma nuclear receptor, known for its essential role in adipocyte differentiation and its potential as a target for diabetes treatment. Overall, his work contributes significantly to our understanding of the molecular underpinnings of metabolic diseases and their interactions with factors such as obesity and inflammation.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.